Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
1,101.371,103.631,105.311,091.41
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
613.35613.35613.35601.49
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
1,198.831,199.681,199.751,182.41
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
1,755.951,754.061,756.031,734.69
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
638.51637.41637.41633.05
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
843.52843.35846.40837.93
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
215.95215.95216.84215.06
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
3,138.913,189.303,230.853,174.76
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
934.37934.72938.26927.50
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
1,477.431,474.121,474.121,451.80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
2,380.192,389.342,403.042,380.47
DYN:NASDAQ
Dyne Therapeutics, Inc
$18.26
-3.39%
(-0.64) 1D
$18.26
0.00% (0.00)
After hours
Closed: Apr 24, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DYN...
Open
$19.48
High
$19.48
Low
$18.12
Mkt. cap
3.01B
Avg. vol.
2.27M
Volume
1.24M
52-wk high
$25.00
52-wk low
$8.06
EPS
-$3.47
Beta
1.29
Shares outstanding
165.22M
No. of employees
258
News stories
From sources across the web
About Dyne Therapeutics, Inc
CEO-
Employees258
Founded2017
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Next call in 8 days
Mon, May 4, 9:30 AM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-0.78 est.)USD
Revenue / Estimate
-/ (0.00 est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
106.45M
99.24M
97.22M
95.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.92M
16.56M
16.67M
20.70M
Operating expense
122.37M
115.79M
113.89M
116.13M
Total operating expenses
122.37M
115.79M
113.89M
116.13M
Operating income
-122.37M
-115.79M
-113.89M
-116.13M
Other non operating income
11.00K
3.00K
-
-
EBT including unusual items
-115.36M
-110.86M
-108.04M
-111.96M
EBT excluding unusual items
-115.36M
-110.86M
-108.04M
-111.97M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-115.36M
-110.86M
-108.04M
-111.96M
Net profit margin
-
-
-
-
Earnings per share
-1.05
-0.97
-0.76
-0.73
Interest and investment income
7.10M
6.62M
8.48M
7.66M
Interest expense
-
-94.00K
-2.90M
-3.19M
Net interest expenses
7.10M
6.53M
5.57M
4.46M
Depreciation and amortization charges
-
-
-
-
EBITDA
-121.87M
-115.29M
-113.37M
-115.61M
Gain or loss from assets sale
95.00K
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more